Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome

Keyphrases

• Cardiac Pacing 100%
• Long QT Syndrome 100%
• β-Adrenergic Blocking Agent 100%
• Combination Therapy 60%
• Beta-blocker Therapy 60%
• Syncope 40%
• QT Interval 40%
• Ventricular Tachycardia 20%
• Adjunctive Therapy 20%
• Primary Therapy 20%
• High Risk 20%
• Sudden Death 20%
• Beta-blockers 20%
• Cardiac Arrest 20%
• Sudden Cardiac Death 20%
• Highly Effective 20%
• Corrected QT Interval 20%
• Sympathectomy 20%
• Pacemaker 20%
• Follow-up Interval 20%
• Specific Rate 20%
• Defibrillator 20%
• T Wave 20%
• Symptom Recurrence 20%
• Lead Fracture 20%
• Cervicothoracic 20%
• Symptomatic Patients 20%
• Wave Sensing 20%
• Pacemaker Function 20%

Nursing and Health Professions

• Beta Adrenergic Receptor Blocking Agent 100%
• Heart Pacing 100%
• Long QT Syndrome 100%
• Combination Therapy 50%
• Pacemaker 33%
• Faintness 33%
• QT Interval 33%
• Sudden Cardiac Death 16%
• Sudden Death 16%
• Recurrent Disease 16%
• Heart Arrest 16%
• QTc Interval 16%
• Polymorphic Ventricular Tachycardia 16%
• Internal Defibrillator 16%
• Lead Fracture 16%
• Sympathectomy 16%
• Adjuvant Therapy 16%
• T Wave 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Beta Adrenergic Receptor Blocking Agent 100%
• Long QT Syndrome 100%
• Combination Therapy 50%
• Faintness 33%
• Recurrent Disease 16%
• Heart Arrest 16%
• Sudden Death 16%
• Polymorphic Ventricular Tachycardia 16%
• Lead Fracture 16%
• Sudden Cardiac Death 16%